Latest Market News

AVITA Medical reported solid 11% revenue growth in 2025 and secured a $60 million credit facility to fuel its next phase of expansion, projecting up to 19% revenue growth in 2026.

Neometals and Mineral Resources’ joint venture Reed Advanced Materials has teamed up with electrochemical leader De Nora to pilot an integrated lithium hydroxide production plant, advancing sustainable battery materials technology.

Summit Minerals has initiated a cutting-edge UAV aeromagnetic survey at its Keystone Project in Nevada, marking the first major exploration there since 1943. The survey aims to refine drilling targets for silver, gold, and tungsten mineralisation.

Deep Yellow Limited confirms Greg Field will start as Managing Director and CEO on 2 February 2026, marking a leadership transition as the company advances its uranium projects in Namibia and Australia.

Monadelphous Group Limited has landed a significant five-year maintenance contract with Rio Tinto, reinforcing its long-standing presence in the Pilbara iron ore operations.

Marquee Resources retracts previous peer comparisons but reports strong Phase 2 drilling results at Mt Clement, confirming high-grade antimony across multiple zones including a newly identified Dugite Zone.

RocketBoots Limited has slightly increased its recent capital raising, issuing an additional 100,000 shares to raise a total of A$7.025 million, reinforcing its push into international markets.

Aland Equity Group Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information explains the recent market activity.

Identitii Limited has locked in a $0.6 million R&D loan facility to bolster its growth amid rising BNDRY platform sales, supported by an expected $0.8 million R&D rebate and a $2.9 million Rights Issue.

The Foreign Investment Review Board has extended its deadline to assess Caterpillar’s proposed acquisition of RPMGlobal, pushing the decision to 23 January 2026. This procedural extension keeps the deal on track but leaves some questions open for shareholders.

Findi Limited secures a strategic A$72 million investment from Nova Global in its Indian subsidiary, Transaction Solutions International, positioning TSI for a strong IPO later this year.

NeuroScientific Biopharmaceuticals reports encouraging clinical responses in fistulising Crohn’s disease patients treated under Australia’s Special Access Scheme, setting the stage for pivotal Phase 2 trials later this year.